CorriXR Therapeutics: Funding, Investors & Team (Sep 2026)
CorriXR Therapeutics is a biotech company based in Wilmington, Delaware, in the United States.
CorriXR Therapeutics has raised $1.0M across 1 funding round on record, the most recent a Series A of $1.0M announced in Aug 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
CorriXR Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2025.
CorriXR Therapeutics Funding Rounds
CorriXR Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
CorriXR Therapeutics Funding Compared to Other Biotechnology Startups
CorriXR Therapeutics' latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like CorriXR Therapeutics in Biotechnology and Wilmington
Companies Similar to CorriXR Therapeutics
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells,…
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
CorriXR Therapeutics Funding FAQs
What does CorriXR Therapeutics do?
CorriXR Therapeutics is a biotech company based in Wilmington, Delaware, in the United States.
How much funding has CorriXR Therapeutics raised?
CorriXR Therapeutics has raised $1.0M across 1 round on record. The most recent is a Series A of $1.0M announced in Aug 2025.
When did CorriXR Therapeutics last raise funding?
CorriXR Therapeutics' most recent funding round on record is a Series A of $1.0M, announced in Aug 2025.
Who founded CorriXR Therapeutics?
FundedIQ lists Eric B Kmiec (Founder) at CorriXR Therapeutics.
Where is CorriXR Therapeutics headquartered?
CorriXR Therapeutics is based in Wilmington, Delaware, United States.
How many employees does CorriXR Therapeutics have?
CorriXR Therapeutics is in the 11-50 employee band.
How does CorriXR Therapeutics' funding compare to other Biotechnology startups?
CorriXR Therapeutics' latest round of $1.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's CorriXR Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CorriXR Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.